top of page

Multi-omics Exploration of Triple Negative Breast Cancer for ADC, Bispecifics and Antibody Drug Development

Thu, Nov 14

|

Webinar

Multi-omics Exploration of Triple Negative Breast Cancer for ADC, Bispecifics and Antibody Drug Development
Multi-omics Exploration of Triple Negative Breast Cancer for ADC, Bispecifics and Antibody Drug Development

Time & Location

Nov 14, 2024, 8:00 AM – 9:00 AM PST

Webinar

About the event

How to leverage multi-omics data to drive innovations in antibody-drug conjugates (ADC), bispecifics, and antibody drug development, particularly for Triple Negative Breast Cancer (TNBC)?


Join us for this webinar to discuss further on this topic with Dr, Brett Pickett (Assistant Professor @ Brigham Young University) and Jenny Pham (Head of Training Programs @ Pythia Biosciences).


In this webinar, you will learn:

- Comparison of methods to determine immune cell signatures in bulk RNA, and their mechanistic contribution to Triple-Negative Breast Cancer

- Combining insights from multi-omics TNBC data to identify potential targets for ADC and bispecifics using C-DIAM Multi-Omics Studio


Date and time: 8AM PST | 11AM EST Thursday November 14, 2024

Share this event

bottom of page